Cidara Therapeutics, Inc. (CDTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 53.87M |
| Enterprise Value | 22.97M |
| Trailing P/E | N/A |
| Forward P/E | 5.75 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.81 |
| Price/Book (mrq) | 14.69 |
| Enterprise Value/Revenue | 0.36 |
| Enterprise Value/EBITDA | -0.94 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.01 |
| 52-Week Change 3 | -41.53% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 29.60 |
| 52 Week Low 3 | 10.00 |
| 50-Day Moving Average 3 | 15.10 |
| 200-Day Moving Average 3 | 16.34 |
Share Statistics
| Avg Vol (3 month) 3 | 60.62k |
| Avg Vol (10 day) 3 | 189.75k |
| Shares Outstanding 5 | 4.56M |
| Implied Shares Outstanding 6 | 4.56M |
| Float 8 | 3.88M |
| % Held by Insiders 1 | 7.34% |
| % Held by Institutions 1 | 30.29% |
| Shares Short (Apr 15, 2024) 4 | 8.17k |
| Short Ratio (Apr 15, 2024) 4 | 0.15 |
| Short % of Float (Apr 15, 2024) 4 | 0.18% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.18% |
| Shares Short (prior month Mar 15, 2024) 4 | 8.97k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:20 |
| Last Split Date 3 | Apr 24, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -35.88% |
| Operating Margin (ttm) | -34.54% |
Management Effectiveness
| Return on Assets (ttm) | -26.72% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 63.91M |
| Revenue Per Share (ttm) | 14.62 |
| Quarterly Revenue Growth (yoy) | 69.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -24.37M |
| Net Income Avi to Common (ttm) | -22.93M |
| Diluted EPS (ttm) | -5.20 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.78M |
| Total Cash Per Share (mrq) | 7.84 |
| Total Debt (mrq) | 4.88M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.90 |
| Book Value Per Share (mrq) | -1.81 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22.43M |
| Levered Free Cash Flow (ttm) | 664.12k |
© 2024 Yahoo. All rights reserved.